Hansen Glen Phd Clinical Investigator is categorized under Pathological Laboratories in Minneapolis, MN and active since 2010.
Hansen Glen Phd Clinical Investigator was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Rita Larson at the company’s single location by writing to 701 Park Avenue, Minneapolis, Minnesota MN 55415 or by phoning (612) 873-3001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hansen Glen Phd Clinical Investigator |
| Contact Person: | Rita Larson |
| Address: | 701 Park Avenue, Minneapolis, Minnesota 55415 |
| Phone Number: | (612) 873-3001 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Hansen Glen Phd Clinical Investigator was started in 2010 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rita Larson for inquiries that concern Hansen Glen Phd Clinical Investigator by calling the company number (612) 873-3001, as your correspondence is most welcome. Additionally, the physical location of the single location of Hansen Glen Phd Clinical Investigator can be found at the coordinates 44.972662,-93.26259 as well as the street address 701 Park Avenue in Minneapolis, Minnesota 55415.
For its online presence, you may visit Hansen Glen Phd Clinical Investigator’s website at and engage with its social media outlets through on Twitter and on Facebook.